Determinants of Diuresis/Natriuresis Following Ambulatory Intravenous Loop Diuretics for Worsening Heart Failure
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15439 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Michael Massin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, University Hospital, Nancy, France. Hauptthemen laut MEDLINE: Heart Failure, Natriuresis, Diuresis, Sodium Potassium Chloride Symporter Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The use of intravenous (IV) diuretics in an outpatient setting may represent an alternative to conventional hospitalization. Our objective was to identify factors associated with diuretic response during ambulatory IV diuretic sessions in a population of advanced heart failure with no therapeutic project and a frequent flyer profile.
Method
All patients with 4-h IV diuretic sessions were analysed. An initial bolus followed a tailored protocol for continuous infusion based on the patient's baseline diuretic dose. Variables associated with diuresis and natriuresis following furosemide infusion were evaluated using mixed linear models.
Results
Seventy-six patients (mean age 75.4 years; LVEF 42.7%; eGFR 40.7 mL/min/1.73 m2) totalling 175 IV diuretic sessions were included. Mean diuresis was 1.0 L, natriuresis 92.6 mmol/L, and weight loss 610 grams. Baseline use of ACE inhibitors (+302 mL, P = 0.0005), eGFR (+160 mL per 10 mL/min/1.73 m2 increase, P < 0.0001), and addition of thiazide during the diuretic session (+238 mL, P = 0.0001) were associated with higher diuresis. Prior percutaneous mitral valve repair or chronic thiazide treatment was associated with lower diuresis. Baseline use of ACE inhibitors (+10.83 mmol/L, P = 0.018) was associated with higher natriuresis. Worsening renal function (>3 mg/L increase from baseline) and dyskalaemia 48 h after these sessions were uncommon (respectively 11% and 15%).
Conclusions
Ambulatory 4-h IV loop diuretic sessions induced a diuresis of approximately 1000 mL with a substantial sodium content, without causing significant complications. Addition of thiazide during the session increased diuresis and/or natriuresis, and could potentially be implemented to maximize the efficacy of ambulatory IV diuretic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, University Hospital, Nancy, France.
- CHRU de Nancy, Centre d'Investigation Clinique Plurithématique 1433, INSERM, Université de Lorraine, INSERM U1116 - DCAC, and F-CRIN INI-CRCT(Cardiovascular and Renal Clinical Trialists), Nancy, France.
- REICATRA, Université de Lorraine, Nancy, France.
- Department of Cardiology, Rambam Health Care Campus, Haifa, Israel.
- Hasselt University, Hasselt, Belgium.
- Ziekenhuis Oost-Limburg, Genk, Belgium.
ORCID-Profile: Michael Massin, Guillaume Baudry, Luca Monzo, Nicolas Girerd
Zitieren
APA
Massin, M., Baudry, G., Duarte, K., Monzo, L., Sadoul, N., Caspi, O., Mullens, W., Huttin, O., & Girerd, N. (2025). Determinants of Diuresis/Natriuresis Following Ambulatory Intravenous Loop Diuretics for Worsening Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.15439
Vancouver
Massin M, Baudry G, Duarte K, Monzo L, Sadoul N, Caspi O, et al. Determinants of Diuresis/Natriuresis Following Ambulatory Intravenous Loop Diuretics for Worsening Heart Failure. ESC Heart Failure. 2025. doi:10.1002/ehf2.15439
BibTeX
@article{Massin2025,
author = {Massin, Michael and Baudry, Guillaume and Duarte, Kevin and Monzo, Luca and Sadoul, Nicolas and Caspi, Oren and Mullens, Wilfried and Huttin, Olivier and Girerd, Nicolas},
title = {Determinants of Diuresis/Natriuresis Following Ambulatory Intravenous Loop Diuretics for Worsening Heart Failure},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15439}
}
EUVIMED